Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  EGFR inhibitor HM61713
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
ELUXA 1: Phase II Trial of HM61713 (BI 1482694) for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 20 and over
Trial IDs: HM-EMSI-202, NCI-2015-01440, 2015-001435-21, NCT02485652
Start Over